It is likely that most neuromusculardiseases thatare describedinhumanswill have acounterpartinour companion animals. With the advent of molecular genetics andthe completion of thecanineand felinegenomes, an ever expandingnumberofDNA-basedtests shouldbecome available forthe diagnosis of muscle andperipheral nerve diseases. Molecular testing proceduresshould enable us to continue to unravel the molecularbasis of neuromusculardiseases forwhich thecause is still unknown. It is importantthataccurate clinical evaluationsand diagnostic testing, including muscle andperipheral nerve biopsies, are performed in ordertoreach thesegoals. This reviewfocusesonrecentlyidentified inherited neuromusculardiseases in companion animals.
Introduction
Most of the recentlyidentified muscleand peripheraln erve diseases (neuromuscular diseases) arebreed associated andfallinto the inherited category (1) (2) (3) . Although inherited neuromusculard iseases in general arerelativelyuncommon; withinabreed,a geneticdisordermay be quitecommon. For example, in arecentstudythatdocumented pyruvate dehydrogenase phosphatase1 (PDP1) deficiencyi nC lumber Spaniels (see p. 252), the carrierr atew as 20% (4) . Geneticd iseases involvingm usclea nd peripheralnervesmay be difficult to diagnose. Fort his group of diseases it is particularly importanttoobtain acorrect neuroanatomic localization,a nd performs pecialized screening andd iagnostic tests, including muscleand peripheralnerve biopsies.
While genetic diseases mostc ommonly occurinanimalsless thanone year of age, there can be aw ide variabilityi na ge of onset.Itisofutmostimportance to reach a correct diagnosis sincethe knowledge of inheritancep atternsi si mportantt ob reeding programs, andmostofthese diseases occur in purebred animals.F urthermore, for the development of DNAbased tests, acorrect diagnosis is critical (5) . The prognosis also differs for the various diseases. Form ost disorders neitheracure nor aspecifictherapyisyet available. Forsome diseases, anabolicagents, dietary changes, and growth factors mayb eb eneficiali na meliorating musclewasting or increasing muscle mass. In the future,pharmacological as well as cell andgenebased therapiesmay be available. Selected inheritedneuromusculardisorders will be discussed to illustrate the featuresof these diseases.
Muscular dystrophies
Muscular dystrophies areah eterogeneous group of inherited,d egenerative, mostly non-inflammatoryd isorders characterized by progressive musclew eakness and wasting (forr eviews see1 ,3 ). In humans,t he geneticb asiso fo ver3 0d ifferent formso f musculardystrophy(MD) hasbeen defined over the past decade. Althoughnot allforms of MD have been identifiedy et in companionanimals, dystrophies associated with an absence of or abnormalities in dystrophin, sarcoglycans, andlaminin alpha 2( Fig.  1 ) have been recognizedi ns everal breeds. SimilartoMDinhumans,dystrophin deficientM Dw ill likelyb et he most common form of MD in animals,given the largesize of dystrophin andp ropensity for mutation. Muscular dystrophyshould be consideredin anyyoung dogorcat (male or female,mixed breed or purebred) with persistent muscle weakness, musclea trophyo rh ypertrophy, gait abnormalityo rc ontracturesb eginning in the firstf ew months of life.S erum creatine kinase (CK)concentrationsare usually dramaticallyelevated. Forclinical purposes, ad iagnosis of MD is made by demonstration of ad ystrophic phenotype in muscle biopsy sections,and immunohistochemical ( Fig. 2) demonstration of decreased or absent dystrophyr elated proteins in muscle. Currentlyt here aren os pecifict reatments availablefor thisgroup of diseases.
Myopathies affecting Labrador Retrievers
Inherited myopathies thataffect the Labrador Retrieverb reed arer elativelyc ommon andc linicians working with this breed should be awareo ft hese disorders as they can mimic orthopaedic or cardiovascular diseases.
Dystrophindeficient muscular dystrophy
Apersistent, markedly elevated CK concentration in ayoung Labrador Retrieverpuppy with am yopathicc linical presentation should provide ap resumptive diagnosis of thisf ormo fm usculard ystrophy ( 1, 3, 6) , differentiating it fromt he other inherited myopathies thataffect this breed.The diagnosis is confirmed by demonstration of a dystrophic phenotype in am uscleb iopsy specimen, and by demonstration of dystrophin deficiency by immunocytochemical or immunoblotting techniques.I fm ultiple puppies in alittera re affected,orthere are known affected relatedd ogs, an inherited 
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familiald isorderw ould be most likely. Spontaneous mutationsa re also possible giventhe propensityofthe dystrophin protein for mutations.
Centronuclearmyopathy
CentronuclearMyopathyused to be known as inheritedmyopathyofLabrador Retrievers, Ty pe 2fibredeficiencyand autosomal recessive musculard ystrophy. Aw idespread inheritedm yopathya ffecting male andfemale, yellowand black Labrador Retrievers less thansix months of agewas first describedi n1 976 (7) . Poor conformation andr educed musclem ass, as tiff' bunny hopping' gait, andabnormal head andneck posturebeginning at ayoung ageare typical clinical findings (Fig. 3) . Multiple littermatesa re usuallya ffected.The serum CK concentration is usuallyn ormal or only mildlye levated. Ap resumptive diagnosis can be made based on appropriatec linical signs ande valuation of muscleb iopsy specimens. Theu nderlying cause of this myopathyeluded clinicians formanyyears, sincepathologicalchangesinmusclebiopsy specimens are variable( 8) andc entraln uclei aren ot evident at ay oung agew hen biopsiesare usuallycollected.Serialinvestigationso fm uscleb iopsies in ac olonyo f Labrador Retrievers in France allowedf or the identification of centralnuclei in muscle of affected dogs at older ages. Thespecific mutation forthis disorderhas recentlybeen identifiedi nt his French pedigree ( 9) . The samem utation is also present in USA and UK pedigrees (Shelton, unpublishedd ata). Aw ebsite is currentlya vailablewith information on genetic testing forthis myopathy (http://www.labradorcnm.com).S pecific therapiesare currentlynot available. Housing in awarmareahas been advisedasexposure to cold maye xacerbate the condition. Supplementation with L-carnitine (50 mg/ kg BID) mayimprovemusclestrength.
Exercise induced collapse in Labrador Retrievers (EIC)
Asyndromeofexercise intoleranceand collapsehas been observedwith increasing frequencyinyoung adult Labrador Retrievers. Most,b ut not all, affected dogs have been from field-trial breeding.Black,yellowand chocolate Labradors of both sexescan be affected.C linical signs become apparent in young dogs as theyencounter heavytraining or performs trenuousa ctivity,b ut usually between sevenmonths andtwo yearsofage. Affected dogs ared escribeda sb eing extremely fit, muscular, andp rime athletic specimens of their breed ( Fig. 4A )with an excitabletemperament andlots of drive (unpublisheddata).
Affected dogs can tolerate mild to moderatee xercise,b ut following 5-20 minutes of strenuousexercise theydevelop profound ataxia followedb ycollapse (Fig. 4B ). Several dogs have died during exercise, or while resting immediately afteranepisode of EIC, henceexercise should always be stoppedat the firstsign of ataxia.This is not amalignant hyperthermia.Affected dogs arerarely able to continue training or competition; however, if theyare removedfrom training andnot exercised excessively,the condition will not progress andt heyw ill be fine as pets. Until now, apresumptive diagnosis of EIC could onlybemadebyruling out other muscle disorders andb yo bservation of characteristic clinical featureswith atypical history. While as pecifict herapy currently doesn ot exist, the avoidanceo fs trenuous activity should result in arelativelynormal lifespan.
AD NA based test for this interesting syndromei so nt he horizon( http://medicine.ucsd.edu/vet_neuromuscular, October 2006 Case of the Month).The chromosomal locus fora nE IC gene hasb een identified with microsatellite DNAmarkers andanassociated DNAm utation hasb een found.A genetict est for confirmation of affected dogs andi dentification of carriers should soon be available. This valuablet est will hopefullyh elpt oe radicatet his disabling disease from breeding populations. 
Pyruvatedehydrogenase phosphatase 1(PDP1) deficiency in Clumber and Sussex Spaniels
Exercise intoleranceand lacticacidosis associated with mitochondrialpyruvatedehydrogenase complexd eficiencyw as describeds everal yearsa go in Clumbera nd SussexSpaniels in the United Kingdom (10, 11) , then manyy earsl ater in aC lumber Spanieli nF inland (12) andt he USAa nd Belgium (13) . Routine laboratory, electrophysiological andhistological examinations aren ormal. Ac onsistent abnormalityi s markedly elevated blood lactate andp yruvate concentrationsw ith al actatet op yruvate ratio (L/P)< 10, ands everem etabolic acidosis. Themeasurement of blood lactate andp yruvatec oncentrationsa tr est and post-exercise is an easy screening procedure andshould be part of aminimumdatabase for anyy oung Clumbero rS ussexS paniel that is admittedw ith exercise intolerance within the firstyear of life.
An ull mutation hasb een identifiedi n PDP1,t he phosphatasee nzyme that activatesthe pyruvate dehydrogenase complex (4). This samem utation affectsb oth the Clumberand SussexSpaniel breeds. In that report, 20% of the currentClumber andSussexSpaniel population arecarriers for anull mutation in PDP1,a nd that homozygosity produces severe exercise intolerance. Knowledgeo ft he moleculard efect has allowedfor the institution of arapid restriction enzyme test for the canine mutation that will allowf or selective breeding.G enetic testing is nowavailablefor confirmation of the PDP1 mutation in Clumber andSussex Spaniels at the University of Missouri-Columbia, USA.I nstructions for sample submissions area vailablea tw ww.caninegen eticdiseases.net.
Although specifictherapies arenot available, dietaryalterations and vitamin supplements mayr esult in clinical improvement. Dogs with PDP1 deficiencya re sensitive to carbohydrateinthe diet and maydevelop lifethreatening acidosis from such diets. Ad iet that is high in fat(50% or more of thecalories in fatand 20% in carbohydrate) leadstoareduction in the concentration of lactate and improvementingeneral condition.Thiamine pyrophosphate is an integral component of the PDH enzyme complexa nd shouldb e supplementeds ince ad ecreased affinity for thecofactormay be overcome by increasing theconcentration. Excessive accumulation of acyl-CoA esters in the mitochondria mayresult in deficiencyo fm uscle carnitine. Supplementation with L-carnitine (50 mg/kg BIDPO) is suggested.Although not yetused clinically, treatmentw ith dichloroacetate mayalso be of benefitbased on the biochemical abnormalities (4).
Glycogenstorage disease type IIIa in Curly-Coated Retrievers
An autosomalr ecessive inheritedd isorder hasrecentlybeen describedincurly-coated Retrievers (CCR) (14) . Glycogen storage diseasetype IIIa (GSDIIIa)isametabolic disorderthatresults fromdeficient activity of the glycogen debranching enzyme (GDE). Intracellularstorageand the retrieval of glucosei sa ffected whichc auses disease primarilyo ft he livera nd skeletal muscle.
Thedogsthatwerediagnosed with GSD IIIa were clinically normal at the time they were neuteredatsix to ninemonths of age. Therew as no historyo fw eakness or exercise intolerance. However, presurgical blood tests revealed high levels of the liver (ALT,A ST,a nd ALP)a nd muscle (CK) enzymesi no therwisen ormal dogs.R ecovery from surgeryw as uneventful, but over the ensuing months andyears, the dogs becamel ethargic,h ad delayedr ecovery from moderate exercise, ands ufferede pisodeso fh ypoglycemic collapset hatr espondedr apidlyt oo rala dministration of glucose-containing supplements.ALT, AST, andA LP activitiess teadilyi ncreased,b ut CK activity hadbeen intermittentlynormal or extremely elevated.
Earlyi nt he course of the disease the clinical signs of GSDI IIa ares ufficiently vague andnon-specificthatitislikelythat some affected dogs have not been diagnosed.Otherthanthe genetictest,the most probablefinding thatcan alertaveterinarian to the problemi sthe elevation of livera nd muscle leakage enzymesi ns erum. However,m anyd ogsh aver outine surgical proceduresw ithout presurgical blood tests, so the disorderm ay not be apparent untilt he dogh as an episodeo fc ollapse or is not as activea se xpected.L iver andm uscle biopsiess howh epatocytes ands cattered myocytes swollen andf ull of glycogen, whichsuggestssome formofglycogenosis. Carriers aree ntirely normal, both in their physicalbehaviourand in blood tests, such as serum transaminase and CK activities. Themutation hasbeen identified at theLaboratoryofComparative Medical Genetics at the Michigan StateU niversity,U SA,a sa single base deletion in the GDEgeneleading to undetectable enzyme production.A polymerase chain reaction (PCR) basedt est is nowa vailable through this laboratoryf or the diagnosis of affected animals andthe detection of obligate carriers,u tilizing simple cheekbrushing,orinasmall sample of blood or semen. Sample submission instructions andforms can be downloadedvia alink from http://www.mmg.msu.edu/faculty/fyfe.htm.
Hypertonicity (episodicfalling) in Cavalier King Charles Spaniels
An electrically silent hypertonicity syndromeb eginning at about three months of agehas been describedinmaleand female CavalierK ing Charles Spanield ogs. The original reports describedd ogsi nt he UK (15) (16) (17) , butsincethen, additional affected dogs have been identifiedi nAustralia and the USA (18) (19) . Allofthe dogs hadahistoryo fe xercise ande xcitement-induced 'collapse' thatw as preceded by a' deerstalking' action or development of a'praying' position (Fig. 5 ). An increase in extensortone of muscles of allfour limbs wasevident during the time of collapsew ith recovery occurring in about 10 minutes.Progression of the disorderh as not been reported,a nd stabilization or improvement mayoccur. While mitochondrialand membranous abnormalities were describedmorphologicallyw ithin muscleb iopsy speci-VetComp OrthopTraumatol4/2007 mens fromd ogsi nt he UK,t heyh aven ot been identifiedinthe USAdogs. Thepathogenesiso ft his condition remains obscure. Thereare some similaritiesofthis disorder to the hyperekplexia or startle disease syndromes describedi nh umans characterized by the presence of an exaggerated startle responsea nd hypertonia following unexpected auditory, visual, or sensory stimuli. Hereditary hyperekplexia hasb een shown to respond dramaticallya lthoughn ot completely to the benzodiazepine drug clonazepam, whiche nhances γ -aminobutyric acid neurotransmission. In severala ffected CKCS dogs thatweretreated with clonazepam, a7 0-80% improvement in clinical signs wasr eported (18) . Ar esolutiono f clinical signs by twoy earso fa ge hasa lso been reported, with the dogs being asymptomatic andnolongerrequiring medication.
Hypertonicity syndromes have also been recognizedinotherbreeds, including ScottishT erriers,S pringerS paniels,W heaton Terriers andB orderT erriers (19) . Hypertonicity associated with paroxysmal episodeso fm yokymia or muscler ippling has recentlybeen characterized in the Jack RussellT errier ( 20) . In general, thesei nvoluntarym ovementd isorders arep oorlyc haracterized in veterinarymedicine.Movement disorders can have different neuroanatomic localizations, including the brain, peripheral lowerm otor neuron, andp ossiblyt he spinalcord,and in some cases, it maybedifficult to preciselyl ocalize. Confusion may also ariseb ecause many of thesep oorly characterized disorders have been giveninaccurate nameso rc haracterizations. Exact diagnosticc riteria mustb ee stablished. Manyofthese syndromes mayhavehuman counterpartsi nw hich geneticm utations have alreadybeen identified. These parallel disorders mayallowgenetic testing of candidate genesinaffected breeds.
Inherited myopathy of Great Dane dogs
Ah ereditary,n on-inflammatorym yopathy with distincth istological myopathicf eatures hasb een describedi ny oung Great Daned ogs ( Fig. 6) (21, 22) . Theo nset of clinical signs is usuallyb efore one year of agea nd both sexesa re affected.C linical signs arec haracterized by exercise intolerance, musclew asting,a nd an exercise-induced tremor.Whileoriginallyreported as a 'centralc ore myopathy' in thisb reed (21) , the histochemicalcharacteristicsofthe distinctcytoarchitecturalstructures differfrom thoseofthe well-characterized centralcore myopathyi nh uman beings. Forc omparative purposes andc onsistencyi nn omenclature,the name of thism yopathyhas been changedt o' Inherited myopathyo f GreatDane' dogs untilthe underlying cause of thisdisease hasbeen identifiedand aspecificm utation hasb een found.F urther studies of thisveryinteresting myopathyare in progress. An autosomalr ecessive mode of inheritance is mostl ikely. No specific treatments areavailable.
Inherited polyneuropathy in Leonbergerdogs
Ad istal, symmetrical,p rogressive polyneuropathyhas been identifiedinseveral relatedL eonberger dogs with ageo fo nset being one to eight years ( 23) . Although it wasn ot reported until2 004, ap olyneuropathyaffecting this breed wassuspected as early as the 1960sinGermany andthe Netherlands. Clinical cases have recentlybeen confirmed in the USA, Canada,U nited Kingdom, France, Germany,T he Netherlands, Belgium,F inland,Swedenand Denmark (Shelton, unpublished data). Theclinical presentation is similartoanaxonalform of hereditarymotor andsensory neuropathy (Charcot-Marie-Tooth disease) describedin humans (24, 25) . Clinicalp resentation includes: exercise intoleranceand weakness, a high steppage pelvicl imb gait, andd yspnoeaa ssociated with laryngeal paralysis. Marked atrophyofthe distallimb muscles is typical with depressed spinalr eflexesa nd weak or absentm ovemento ft he laryngeal andpharyngeal muscles. Electrophysiological evaluation andm uscleb iopsy findings arec onsistent with denervation.P eripheral nervebiopsies show nervefibreloss, axonal degeneration, ands econdary demyelination.A lthougha nX -linked modeo fi nheritancewas initiallyconsideredbased on pedigreea nalysis, an autosomal recessive inheritancecannot be ruledout.
Form anyr easons,c linicians undera ppreciatethe frequencyand variabilityofinherited neuropathies (24) . The ageofonset is variable, andc linical signs in the same disordercan begin at afew months of age, or not untilanolderage.For example, in Leonberger dogs with inherited polyneuropathy, the ageofonset can range from one to three yearsu pt oe ightt on ine yearso fa ge,a lthoughthe disease tendstobemore severe in the youngera ge group (Shelton, unpublished data). Theonset of disease maybeinsidious andn ot be recognizedf or many years, whichsuggestsfalse information regarding the course of disease. Thedog may be consideredt ob e' clumsy', have unexplainedorthopaedic injuries, or treatment of an 'acquired'disease maybeunresponsive. Finally, inheritedn europathiesa re often painless andt hus neurologic impairments mayg ou nnoticed.The involvemento fr elatedanimalsmay be incorrectly attributed to another cause. Thec ritical assessment andc orrect identification of peripheral nerved isease mayp revent unnecessaryo r harmful treatments.Agood neurological evaluation can help to avoid misdiagnosis.
Thereare reports of inherited polyneuropathies thataffect other breedsofdogsand cats ( 26) . Recently, laryngeal paralysispolyneuropathyc omplex with concurrent megaesophagus wasr eported in young relatedPyrenean Mountain Dogs (27) . Adistals ensorimotor polyneuropathyh as been reportedi nm ature Rottweilerd ogs ( 28) . Adult-onset breed-associated polyneuropathies also likelyoccurinthe ItalianSpimoni (3) andBouvier desFlandres (Fig. 7) (29) dogs.Asensory neuropathyh as been identifiedinyoung BorderCollie dogs (30, 31) . Theunderlying cause is notyet known for anyo ft hese neuropathies ands pecific mutationshavenot yetbeen identified.
Discussion
Our knowledgeofthe spectrum of inherited neuromusculardiseases in companionanimals,a nd neuromusculard iseases in general,has widely expandedo verthe past 10 years( 32) andw ill continue to do so.The importanceo fi ncluding neuromuscular diseases in the differentiald iagnosis in dogs with exercise intolerancea nd weakness, of astute clinicians reaching an accurate clinical assessment, ando fp athologists trainedinmuscleand nervediseases reaching ac orrect diagnosis, cannot be stressed enough. In the past,c ases with chronic muscleatrophy, gait abnormalities, contractures, and weakness carriedapoor prognosis as ad iagosisc ould rarely be made,and unlessinflammatory, there were not anya vailabletreatments.Itisstill true thatsome muscle andperipheral nervediseases aretreatable,and that others arenot. As the molecularbasisofmore muscle and peripheralnerve diseases becomesknown, newt reatment optionsm ay become available,and genetictesting procedurescan be developed in ordert oe liminate inherited musclea nd nerved iseases from breeding programs. 
